Drukuj

Komórki kompetentne, szczepy ekspresyjne, Novagen® BL21, Merck

Dostawca: Merck

71252-4EA 2870 PLN
71252-4 70236-4 70235-4 70236-3 70235-3 69449-3 71252-3 69449-4 69450-3 69451-3 69450-4 69451-4
Komórki kompetentne, szczepy ekspresyjne, Novagen® BL21, Merck
Komórki kompetentne
A common method for transformation of plasmids into E.coli is the use of chemically competent cells. Although competent cells can be prepared in the laboratory, greater efficiency, reproducibility, and convenience are achieved using Novagen® prepared competent cells. Every Novagen® competent cell strain is verified for phenotype and purity, and is guaranteed for transformation efficiency.

DE3 indicates that the host is a lysogen of λDE3, and therefore carries a chromosomal copy of the T7 RNA polymerase gene under control of the lacUV5 promoter. Such strains are suitable for production of protein from target genes cloned in pET vectors by induction with IPTG.

pLysS strains express T7 lysozyme, which further suppresses basal expression of T7 RNA polymerase prior to induction, thus stabilising pET recombinants encoding target proteins that affect cell growth and viability.

The standard volume per tube is 0,2 ml, which provides enough cells for ten transformations. All kits are supplied with SOC medium and test plasmid. Several strains are also available as Singles™ Competent Cells, which are provided in single-use, 50 μl volumes for extra convenience and efficiency.

BL21 strains are the most widely used hosts for protein expression from pET recombinants and have the advantage of being deficient in both lon and ompT proteases.
Zobacz ceny

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Więcej About VWR